Keyword: Nkarta

Nkarta Therapeutics

The commercial potential of CAR-Ts is constrained by a range of logistical and safety issues. Nkarta thinks engineered natural killer cells can eliminate those constraints, resulting in better therapies equipped to go mainstream.